Ralph Schiess
Ralph Schiess
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei imsb.biol.ethz.ch
Titel
Zitiert von
Zitiert von
Jahr
Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins
B Wollscheid, D Bausch-Fluck, C Henderson, R O'brien, M Bibel, ...
Nature biotechnology 27 (4), 378-386, 2009
4662009
Targeted proteomic strategy for clinical biomarker discovery
R Schiess, B Wollscheid, R Aebersold
Molecular oncology 3 (1), 33-44, 2009
3612009
On the development of plasma protein biomarkers
S Surinova, R Schiess, R Hüttenhain, F Cerciello, B Wollscheid, ...
Journal of proteome research 10 (1), 5-16, 2011
3082011
PASSEL: The P eptide A tlas SRM experiment library
T Farrah, EW Deutsch, R Kreisberg, Z Sun, DS Campbell, L Mendoza, ...
Proteomics 12 (8), 1170-1175, 2012
1762012
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer
I Cima, R Schiess, P Wild, M Kaelin, P Schüffler, V Lange, P Picotti, ...
Proceedings of the National Academy of Sciences 108 (8), 3342-3347, 2011
1752011
A mass spectrometric-derived cell surface protein atlas
D Bausch-Fluck, A Hofmann, T Bock, AP Frei, F Cerciello, A Jacobs, ...
PloS one 10 (4), e0121314, 2015
1672015
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ...
European urology 64 (1), 150-158, 2013
1102013
Analysis of cell surface proteome changes via label-free, quantitative mass spectrometry
R Schiess, LN Mueller, A Schmidt, M Mueller, B Wollscheid, R Aebersold
Molecular & Cellular Proteomics 8 (4), 624-638, 2009
902009
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
C Rothermundt, S Hayoz, AJ Templeton, R Winterhalder, RT Strebel, ...
European urology 66 (3), 468-474, 2014
852014
Direct selection of antibodies from complex libraries with the protein fragment complementation assay
H Koch, N Gräfe, R Schiess, A Plückthun
Journal of molecular biology 357 (2), 427-441, 2006
672006
N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications
R Hüttenhain, S Surinova, R Ossola, Z Sun, D Campbell, F Cerciello, ...
Molecular & Cellular Proteomics 12 (4), 1005-1016, 2013
522013
A DNA-damage selective role for BRCA1 E3 ligase in claspin ubiquitylation, CHK1 activation, and DNA repair
K Sato, E Sundaramoorthy, E Rajendra, H Hattori, AD Jeyasekharan, ...
Current biology 22 (18), 1659-1666, 2012
472012
Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome
M Kälin, I Cima, R Schiess, N Fankhauser, T Powles, P Wild, A Templeton, ...
European urology 60 (6), 1235-1243, 2011
472011
Defining potentially conserved RNA regulons of homologous zinc-finger RNA-binding proteins
T Scherrer, C Femmer, R Schiess, R Aebersold, AP Gerber
Genome biology 12 (1), 1-19, 2011
412011
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)
R Cathomas, C Rothermundt, D Klingbiel, L Bubendorf, R Jaggi, ...
Clinical cancer research 18 (21), 6049-6057, 2012
342012
Comprehensive description of the N-glycoproteome of mouse pancreatic β-cells and human islets
C Danzer, K Eckhardt, A Schmidt, N Fankhauser, S Ribrioux, ...
Journal of proteome research 11 (3), 1598-1608, 2012
342012
Biomarker validation in blood specimens by selected reaction monitoring mass spectrometry of N-glycosites
R Ossola, R Schiess, P Picotti, O Rinner, L Reiter, R Aebersold
Serum/Plasma Proteomics, 179-194, 2011
232011
Similarities and differences of blood N-Glycoproteins in five solid carcinomas at localized clinical stage analyzed by SWATH-MS
T Sajic, Y Liu, E Arvaniti, S Surinova, EG Williams, R Schiess, ...
Cell reports 23 (9), 2819-2831. e5, 2018
172018
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
T Steuber, P Tennstedt, A Macagno, A Athanasiou, A Wittig, R Huber, ...
BJU international 123 (5), 826-833, 2019
62019
Everolimus as first-line therapy in nonrapidly progressive metastatic castration-resistant prostate cancer (mCRPC): A multicenter phase II trial (SAKK 08/08).
A Templeton, C Rothermundt, R Cathomas, D Baertschi, C Droege, ...
Journal of Clinical Oncology 29 (15_suppl), 4588-4588, 2011
52011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20